172 related articles for article (PubMed ID: 29226890)
1. Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yıldırım E; Çelik M; Yüksel UÇ; Buğan B; Gökoğlan Y; Görmel S; Yaşar S; Koklu M; İyisoy A; Barçın C
Turk Kardiyol Dern Ars; 2017 Dec; 45(8):702-708. PubMed ID: 29226890
[TBL] [Abstract][Full Text] [Related]
2. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
[TBL] [Abstract][Full Text] [Related]
4. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
Kurtul A
Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Recurrent With First-Time In-Stent Restenosis.
Zhang H; Zhang Y; Tian T; Wang T; Chen J; Yuan J; Qian J; Hu F; Dou K; Qiao S; Wu Y; Guan C; Yang W; Song L
Am J Cardiol; 2023 Nov; 206():168-174. PubMed ID: 37708747
[TBL] [Abstract][Full Text] [Related]
7. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
8. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents.
Lee MS; Yang T; Mahmud E; Park KW; Kim HS; Kim MH; Dangas G; Hermiller J; Krucoff M; Rutledge D
J Invasive Cardiol; 2014 Sep; 26(9):420-6. PubMed ID: 25198484
[TBL] [Abstract][Full Text] [Related]
11. Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.
Moussa ID; Mohananey D; Saucedo J; Stone GW; Yeh RW; Kennedy KF; Waksman R; Teirstein P; Moses JW; Simonton C
J Am Coll Cardiol; 2020 Sep; 76(13):1521-1531. PubMed ID: 32972528
[TBL] [Abstract][Full Text] [Related]
12. Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease.
Zheng WP; Yang M; Su LX; Ning Y; Wen WW; Xin MK; Zhao X; Zhang M
Clin Chim Acta; 2017 Aug; 471():150-153. PubMed ID: 28558956
[TBL] [Abstract][Full Text] [Related]
13. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
15. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis.
Demyanets S; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Wonnerth A; Weiss TW; Wojta J; Speidl WS; Huber K
Cytokine; 2014 Jun; 67(2):65-70. PubMed ID: 24725541
[TBL] [Abstract][Full Text] [Related]
16. Impact of anemia on in-stent restenosis after percutaneous coronary intervention.
Hu H; Wang S; Tang G; Zhai C; Shen L
BMC Cardiovasc Disord; 2021 Nov; 21(1):548. PubMed ID: 34798833
[TBL] [Abstract][Full Text] [Related]
17. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Nutritional Index as a Novel Predictor of In-Stent Restenosis: A Retrospective Study.
Balun A; Akgümüş A; Özbek K; Güven Çetin Z
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109621
[No Abstract] [Full Text] [Related]
19. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
20. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ
Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
